STAT3 and autosomal dominant polycystic kidney disease: In addition, others have reported that JAK2-STAT3 is activated in polycystic kidney disease (PKD) and STAT3 inhibitors like pyrimethamine could inhibit ADPKD cell proliferation and alleviate disease progression in Pkd1 mice [30,31,32].